Pharma, Ranbaxy Lab, Aurobindo, Glenmark Pharma, Strides Arcolab, Divi's Lab, Lupin and Cipla are up 1-6% on SI Reporter | Mumbai September 29, 2014 Last Updated at 11:00 IST Shares of pharmaceutical companies are on a roll with most of the frontline stocks ... Business Standard, 3 weeks ago
Sensex inches towards 27000; HDFC twins, pharma lead - Money Control, 1 month ago
Pharma Leader Series - Leading Pharmaceutical Contract Manufacturing Organisations (CMOs) 2014-2024 - MRO-Esource.com, 3 weeks ago
More from: NDTV, NDTV Profit...and 1 other sources
1 images for "ranbaxy lab"
Akshata Deshmukh, Chief Strategist-Trading at Networth Stock Broking is of the view that one may hold Ranbaxy Laboratories with a target of Rs 750-770.Money Control, 2 months ago Bull's Eye: Buy Lupin, HDFC; short HDIL, Reliance Capital Money Control, 1 month ago Hold Ranbaxy Labs; target of Rs 615: KRChoksey Money Control, 2 months ago Buy Ranbaxy Labs; target of Rs 605: Motilal Oswal Money Control, 2 months ago
With the fresh exits, nearly half of the members who were part of Ranbaxy’s executive committee two years ago will no longer be part of the team. NEW DELHI: Ranbaxy Laboratories' global HR head Sandeep Girotra has stepped down while its president of ...Economic Times, 2 months ago
Ranbaxy Laboratories is currently trading at Rs. 601.75, up by 3.70 points or 0.62% from its previous closing of Rs. 598.05 on the BSE. The scrip opened at Rs. 598.00 and has touched a high and low of Rs. 604.50 and Rs. 596.25 respectively. So far ...Arihant Capital, 1 week ago
The CID is a request for documents and information, and is not an allegation of wrongdoing or demand for compensation. Ranbaxy Laboratories Ltd has announced that the Company has received a Civil Investigative Demand ("CID") from the United States Department ...India Infoline, 1 month ago Ranbaxy Labs. - Receipt of Civil Investigative Demand ("CID"... SBICAP Securities, 1 month ago Ranbaxy Labs. - Communication received from the Competition... SBICAP Securities, 1 month ago
Under the settlement agreement, Ranbaxy, which will soon become a subsidiary of Sun Pharma, will pay USD 39.75 million to State of Texas in a series of tranches through August 2015.Money Control, 1 week ago Ranbaxy Laboratories settles litigation; will pay USD 39.75mn to State of Texas Moneycontrol.com, 1 week ago
Ranbaxy Laboratories Ltd has informed BSE that the Company has notified the Bank of New York Mellon (hereinafter R anbaxy Laboratories Ltd has informed BSE that the Company has notified the Bank of New York Mellon (hereinafter "The Bank") to ...Moneycontrol.com, 1 week ago Ranbaxy Laboratories' Q2 results on October 28, 2014 Moneycontrol.com, 3 weeks ago Ranbaxy Laboratories receives direction from CCI Moneycontrol.com, 1 month ago
According to Satish Gupta of astrostocktips, pharma stocks like Dr Reddy's Labs, Ranbaxy Labs, Sun Pharma and Glenmark Pharma will get astro support.Money Control, 1 week ago Cipla, TCS, Ranbaxy, Polaris to get astro support: Gupta Money Control, 1 month ago
Reliance Industries | DLF | Bajaj Auto | Liberty Shoes | ILFS Engineering | Tata Power | Ranbaxy Labs | UCO Bank | UPL | Novartis India and Tata Steel are stocks, which are in the news today.Money Control, 1 week ago
12:06 am New Delhi : Launching the first-ever public scrutiny of an M&A deal in India, fair trade watchdog CCI said it has prima facie found that the $4-billion merger of Ranbaxy Labs into rival Sun Pharma is likely to have an appreciable adverse ...The Freepress Journal, 1 month ago Sun-Ranbaxy deal may hit fair trade: CCI Times of India, 1 month ago Sun-Ranbaxy deal may hit competition: CCI VC Circle, 1 month ago CCI begins Sun-Ranbaxy deal's public scrutiny; seeks notes Moneycontrol.com, 1 month ago
on your WebpageAdd Widget >Get your members hooked!